// App-Quantinova.ai

S232 : DISEASE RISK IN TP53 MUTANT ACUTE MYELOID LEUKAEMIA FOLLOWING AN ALLOGENEIC STEM CELL TRANSPLANT IS DEPENDENT ON THE PRESENCE OF CO-EXISTING CYTOGENETIC FEATURES: A REPORT FROM THE ALWP OF THE EBMT

Researchers

Presenter

  • Justin Loke

Principal Investigators

  • Charles Craddock

  • Jan Cornelissen

  • Hlne Labussire-Wallet

  • Eva Maria Wagner-Drouet

  • Gwendolyn Van Gorkom

  • Nicolaas Schaap

  • Nicolaus Krger

  • Joan Hendrik Veelken

  • Montserrat Rovira

  • Anne Lise Menard

  • Hans Martin

  • Gesine Bug

  • Ali Bazarbachi

  • Sebastian Giebel

  • Eolia Brissot

  • Arnon Nagler

  • Jordi Esteve

  • Mohamad Mohty

Medical Centers

  • Leiden University Hospital, Leiden, The Netherlands,

  • CRLCC Henri Becquerel, Rouen, France

  • European Society for Blood and Marrow Transplantation,Paris,France

  • Maria Sklodowska-Curie Institute – Oncology Center,Gilwice,Poland

  • Erasmus MC, Rotterdam, Netherlands

  • Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Goethe University, Frankfurt, Germany

  • Hopital Lyon Sud,Lyon,France

  • Saint Antoine Hospital, paris, France

  • University Hospital Maastricht, Maastricht, Netherlands

  • University Medical Center Mainz, Mainz, Germany

  • Radboud University Medical Center, Njmegen, Netherlands

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

  • American University of Beirut (AUB), Beirut, Lebanon

  • Centre for Clinical Haematology - Queen Elizabeth Hospital, Birmingham, United Kingdom,

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom

Locations

  • Netherlands

  • France

  • Poland

  • Israel

  • Germany

  • Lebanon

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved